Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
|
|
Sexually Transmitted Diseases Vol. 35; No. 11: P. 930-934 (11..08) - Monday, December 15, 2008
Gini G.C. Van Rijckevorsel, MD, MSc; Gerard J.B. Sonder, MD, PhD, MSc; Lian P.M.J. Bovee, MSc; Harold F.J. Thiesbrummel, MD; Ronald B. Geskus, PhD; Anneke Van Den Hoek, MD, PhD
Data of all reported hepatitis A, acute hepatitis B, and shigellosis between Jan. 1, 1992, and Dec. 31, 2006, were examined, as were data from all patients newly diagnosed with gonorrhea and infectious syphilis at Amsterdam's Public Health Service STI outpatient department for this period.
Hepatitis A incidence remained unchanged in MSM (mean 0.97 per 1,000 MSM, range 0.04-2.27), who comprised 21 percent of all 1,697 infections. Likewise, hepatitis B remained unchanged in MSM (mean 0.47 per 1,000 MSM, range 0.19-0.77), who had 41 percent of all 448 infections. Shigellosis is mostly travel- related (657/974), and 16 percent of cases occurred in MSM. Its incidence dropped in general, but not in MSM. Both infectious syphilis and gonorrhea in MSM showed steep increases, primarily after 1998.
"Hepatitis A, B, and shigellosis do not follow the rising trends of conventional STI in MSM, which are believed to result from increased risky sexual behavior," the authors concluded. "This disparity in trends implies differences in transmission dynamics. Recent molecular epidemiological studies suggest that clustered transmission in social MSM networks plays a major role."
081215
AD082344
Copyright © 2008 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.